Crossmark

Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab

Crossref DOI link: https://doi.org/10.1016/j.endien.2021.08.007

Published Print: 2021-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rodríguez de Vera Gómez, Pablo

Tous Romero, María del Castillo

Morales Portillo, Cristóbal

Serrano Olmedo, Isabel

Martínez Brocca, María Asunción
License Information

Text and Data Mining valid from 2021-05-01
More Information

This article is maintained by: Elsevier

Article Title: Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2021.08.007

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.endinu.2020.07.005

Content Type: simple-article

Copyright: © 2020 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.